Abstract
A frameshift mutation in the transcript of the ubiquitin-B gene leads to a C-terminally extended ubiquitin (Ub), UBB+1. UBB+1 has been considered to inhibit proteasomes and as such to be the underlying cause for toxic protein buildup correlated with certain neuropathological conditions. We demonstrate that expression of extended Ub variants leads to accumulation of heterogeneously linked polyubiquitin conjugates, indicating a pervasive effect on Ub-dependent turnover. 20S proteasomes selectively proteolyzed Ub extensions, yet no evidence for inhibition of 26S holoenzymes was found. However, among susceptible targets for inhibition was Ubp6, the primary enzyme responsible for disassembly of Lys48 linkages at 26S proteasomes. Processing of Lys48 and Lys63 linkages by other deubiquitinating enzymes (DUBs) was also inhibited. Disruption of Ub-dependent degradation by extended Ub variants may therefore be attributed to their inhibitory effect on select DUBs, thus shifting research efforts related to protein accumulation in neurodegenerative processes from proteasomes to DUBs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Glickman, M.H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373–428 (2002).
Finley, D., Ulrich, H.D., Sommer, T. & Kaiser, P. The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics 192, 319–360 (2012).
Komander, D. Mechanism, specificity and structure of the deubiquitinases. Subcell. Biochem. 54, 69–87 (2010).
Lee, M.J., Lee, B.H., Hanna, J., King, R.W. & Finley, D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell. Proteomics 10, R110.003871 (2011).
Guterman, A. & Glickman, M.H. Complementary roles for Rpn11 and Ubp6 in deubiquitination and proteolysis by the proteasome. J. Biol. Chem. 279, 1729–1738 (2004).
Koulich, E., Li, X. & DeMartino, G.N. Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol. Biol. Cell 19, 1072–1082 (2008).
Ziv, I. et al. A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis. Mol. Cell Proteomics 10, M111.009753 (2011).
Dammer, E.B. et al. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 286, 10457–10465 (2011).
Sun, L. & Chen, Z.J. The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. 16, 119–126 (2004).
Saeki, Y. et al. Lysine 63–linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J. 28, 359–371 (2009).
Nathan, J.A., Kim, H.T., Ting, L., Gygi, S.P. & Goldberg, A.L. Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? EMBO J. 32, 552–565 (2013).
Nakasone, M.A., Livnat-Levanon, N., Glickman, M.H., Cohen, R.E. & Fushman, D. Mixed-linkage ubiquitin chains send mixed messages. Structure 21, 727–740 (2013).
Newman, A.J. Pre-mRNA splicing. Curr. Opin. Genet. Dev. 4, 298–304 (1994).
Maquat, L.E. Nonsense-mediated mRNA decay. Curr. Biol. 12, R196–R197 (2002).
van Leeuwen, F.W. et al. Frameshift mutants of β-amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242–247 (1998).
Ko, S. et al. Structural basis of E2–25K/UBB+1 interaction leading to proteasome inhibition and neurotoxicity. J. Biol. Chem. 285, 36070–36080 (2010).
Lindsten, K. et al. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 157, 417–427 (2002).
van Tijn, P. et al. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease. Neurochem. Int. 61, 739–748 (2012).
Wu, S.S. et al. Coexpression and accumulation of ubiquitin +1 and ZZ proteins in livers of children with α1-antitrypsin deficiency. Pediatr. Dev. Pathol. 5, 293–298 (2002).
Fratta, P. et al. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers. Neurology 63, 1114–1117 (2004).
de Pril, R. et al. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. Hum. Mol. Genet. 13, 1803–1813 (2004).
Lam, Y.A. et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 97, 9902–9906 (2000).
Verhoef, L.G. et al. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates. FASEB J. 23, 123–133 (2009).
Dennissen, F.J.A. et al. Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3). FEBS Lett. 585, 2568–2574 (2011).
Matiuhin, Y. et al. Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome. Mol. Cell 32, 415–425 (2008).
Shabek, N. et al. The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation. Mol. Cell 48, 87–97 (2012).
Shabek, N., Iwai, K. & Ciechanover, A. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target. Biochem. Biophys. Res. Commun. 363, 425–431 (2007).
Dantuma, N.P., Lindsten, K., Glas, R., Jellne, M. & Masucci, M.G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18, 538–543 (2000).
Shabek, N. & Ciechanover, A. Degradation of ubiquitin: the fate of the cellular reaper. Cell Cycle 9, 523–530 (2010).
Shabek, N., Herman-Bachinsky, Y. & Ciechanover, A. Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc. Natl. Acad. Sci. USA 106, 11907–11912 (2009).
Fu, H., Reis, N., Lee, Y., Glickman, M.H. & Vierstra, R.D. Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J. 20, 7096–7107 (2001).
Glickman, M.H. et al. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94, 615–623 (1998).
Rinaldi, T. et al. Participation of the proteasomal lid subunit Rpn11 in mitochondrial morphology and function is mapped to a distinct C-terminal domain. Biochem. J. 381, 275–285 (2004).
Gattiker, A., Bienvenut, W.V., Bairoch, A. & Gasteiger, E. FindPept, a tool to identify unmatched masses in peptide mass fingerprinting protein identification. Proteomics 2, 1435–1444 (2002).
Nussbaum, A.K., Kuttler, C., Hadeler, K.P., Rammensee, H.G. & Schild, H. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics 53, 87–94 (2001).
van Tijn, P. et al. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease. J. Cell Sci. 120, 1615–1623 (2007).
Hanna, J. et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127, 99–111 (2006).
Rosenzweig, R., Bronner, V., Zhang, D., Fushman, D. & Glickman, M.H. Rpn1 and Rpn2 coordinate ubiquitin processing factors at proteasome. J. Biol. Chem. 287, 14659–14671 (2012).
Takeuchi, J., Chen, H. & Coffino, P. Proteasome substrate degradation requires association plus extended peptide. EMBO J. 26, 123–131 (2007).
Bajorek, M., Finley, D. & Glickman, M.H. Proteasome disassembly and downregulation is correlated with viability during stationary phase. Curr. Biol. 13, 1140–1144 (2003).
Metcalfe, M.J., Huang, Q. & Figueiredo-Pereira, M.E. Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis. 3, e326 (2012).
Peth, A., Kukushkin, N., Bosse, M. & Goldberg, A.L. Ubiquitinated proteins activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs. J. Biol. Chem. 288, 7781–7790 (2013).
Lee, B.H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179–184 (2010).
D'Arcy, P. et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med. 17, 1636–1640 (2011).
Nag, D.K. & Finley, D. A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication. Virus Res. 165, 103–106 (2012).
Yao, T. & Cohen, R.E. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419, 403–407 (2002).
Sato, Y. et al. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature 455, 358–362 (2008).
Spires-Jones, T.L., Stoothoff, W.H., de Calignon, A., Jones, P.B. & Hyman, B.T. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 32, 150–159 (2009).
Wooten, M.W. et al. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J. Biol. Chem. 283, 6783–6789 (2008).
Glickman, M. & Coux, O. Purification and characterization of proteasomes from Saccharomyces cerevisiae. Curr Protoc Protein Sci Chapter 21, Unit 21 5 (2001).
Raasi, S., Varadan, R., Fushman, D. & Pickart, C.M. Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat. Struct. Mol. Biol. 12, 708–714 (2005).
Hofmann, R.M. & Pickart, C.M. In vitro assembly and recognition of Lys-63 polyubiquitin chains. J. Biol. Chem. 276, 27936–27943 (2001).
Datta, A.B., Hura, G.L. & Wolberger, C. The structure and conformation of Lys63-linked tetraubiquitin. J. Mol. Biol. 392, 1117–1124 (2009).
Johnston, S.C., Riddle, S.M., Cohen, R.E. & Hill, C.P. Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J. 18, 3877–3887 (1999).
Deveraux, Q., Ustrell, V., Pickart, C. & Rechsteiner, M. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269, 7059–7061 (1994).
Kirkpatrick, D.S., Gerber, S.A. & Gygi, S.P. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods 35, 265–273 (2005).
Kirkpatrick, D.S. et al. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol. 8, 700–710 (2006).
Acknowledgements
This research was funded by US National Institutes of Health grant GM095755 to D.F. and M.H.G. and a USA-Israel Binational Science Foundation grant (2009487) to D.F. and M.H.G.
Author information
Authors and Affiliations
Contributions
D.K., M.H.G., N.R., M.A.N. and D.F. designed experiments. D.K. carried out in vivo and in vitro proteasomal experiments. S.P.G. and D.S.K. aided in aqua analysis. M.A.N. and D.Z. synthesized all of the Ub conjugates. A.B. and P.S. collected and analyzed processed Ub fragments. D.K., M.A.N. and M.G.H. prepared the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Results, Supplementary Tables 1–6 and Supplementary Figures 1–5. (PDF 972 kb)
Rights and permissions
About this article
Cite this article
Krutauz, D., Reis, N., Nakasone, M. et al. Extended ubiquitin species are protein-based DUB inhibitors. Nat Chem Biol 10, 664–670 (2014). https://doi.org/10.1038/nchembio.1574
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1574
This article is cited by
-
Altered ubiquitin signaling induces Alzheimer’s disease-like hallmarks in a three-dimensional human neural cell culture model
Nature Communications (2023)
-
The 20S as a stand-alone proteasome in cells can degrade the ubiquitin tag
Nature Communications (2021)